Global Recombinant Plasma Proteins Market Growth (Status and Outlook) 2025-2031
According to this study, the global Recombinant Plasma Proteins market size will reach US$ 109 million by 2031.
For almost 50 years, the fractionation of human plasma has been the sole possible source of a wide range of therapeutic proteins--such as coagulation factors, anticoagulants, immunoglobulins, and albumin--essential to the treatment of serious congenital or acquired bleeding or immunological diseases. In the last 20 years, the application of recombinant technologies to mammalian cell cultures has made possible--although with some limitations in productivity, costs, and immunogenic risks-
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
LPI (LP Information)' newest research report, the “Recombinant Plasma Proteins Industry Forecast” looks at past sales and reviews total world Recombinant Plasma Proteins sales in 2024, providing a comprehensive analysis by region and market sector of projected Recombinant Plasma Proteins sales for 2025 through 2031. With Recombinant Plasma Proteins sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Plasma Proteins industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Plasma Proteins landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Recombinant Plasma Proteins portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Plasma Proteins market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Plasma Proteins and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Plasma Proteins.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Plasma Proteins market by product type, application, key players and key regions and countries.
Segmentation by Type:
For almost 50 years, the fractionation of human plasma has been the sole possible source of a wide range of therapeutic proteins--such as coagulation factors, anticoagulants, immunoglobulins, and albumin--essential to the treatment of serious congenital or acquired bleeding or immunological diseases. In the last 20 years, the application of recombinant technologies to mammalian cell cultures has made possible--although with some limitations in productivity, costs, and immunogenic risks-
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
LPI (LP Information)' newest research report, the “Recombinant Plasma Proteins Industry Forecast” looks at past sales and reviews total world Recombinant Plasma Proteins sales in 2024, providing a comprehensive analysis by region and market sector of projected Recombinant Plasma Proteins sales for 2025 through 2031. With Recombinant Plasma Proteins sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Plasma Proteins industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Plasma Proteins landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Recombinant Plasma Proteins portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Plasma Proteins market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Plasma Proteins and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Plasma Proteins.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Plasma Proteins market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Chinese Hamster Ovary (CHO) Cell Line
- Baby Hamster Kidney (BHK) Cell Line
- Human Embryonic Kidney (HEK) Cell Line
- Others
- Hemophilia A
- Hemophilia B
- Von Willebrand Disease
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- CSL Limited
- Shire (Takeda Pharmaceutical Company Limited)
- Octapharma
- Novo Nordisk
- Bayer
- Bioverativ Therapeutics, Inc. (Sanofi)
- Aptevo Therapeutics
- Pharming Group
- Pfizer
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant Plasma Proteins Market Size (2020-2031)
2.1.2 Recombinant Plasma Proteins Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Recombinant Plasma Proteins by Country/Region (2020, 2024 & 2031)
2.2 Recombinant Plasma Proteins Segment by Type
2.2.1 Chinese Hamster Ovary (CHO) Cell Line
2.2.2 Baby Hamster Kidney (BHK) Cell Line
2.2.3 Human Embryonic Kidney (HEK) Cell Line
2.2.4 Others
2.3 Recombinant Plasma Proteins Market Size by Type
2.3.1 Recombinant Plasma Proteins Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Recombinant Plasma Proteins Market Size Market Share by Type (2020-2025)
2.4 Recombinant Plasma Proteins Segment by Application
2.4.1 Hemophilia A
2.4.2 Hemophilia B
2.4.3 Von Willebrand Disease
2.4.4 Others
2.5 Recombinant Plasma Proteins Market Size by Application
2.5.1 Recombinant Plasma Proteins Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Recombinant Plasma Proteins Market Size Market Share by Application (2020-2025)
3 RECOMBINANT PLASMA PROTEINS MARKET SIZE BY PLAYER
3.1 Recombinant Plasma Proteins Market Size Market Share by Player
3.1.1 Global Recombinant Plasma Proteins Revenue by Player (2020-2025)
3.1.2 Global Recombinant Plasma Proteins Revenue Market Share by Player (2020-2025)
3.2 Global Recombinant Plasma Proteins Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RECOMBINANT PLASMA PROTEINS BY REGION
4.1 Recombinant Plasma Proteins Market Size by Region (2020-2025)
4.2 Global Recombinant Plasma Proteins Annual Revenue by Country/Region (2020-2025)
4.3 Americas Recombinant Plasma Proteins Market Size Growth (2020-2025)
4.4 APAC Recombinant Plasma Proteins Market Size Growth (2020-2025)
4.5 Europe Recombinant Plasma Proteins Market Size Growth (2020-2025)
4.6 Middle East & Africa Recombinant Plasma Proteins Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Recombinant Plasma Proteins Market Size by Country (2020-2025)
5.2 Americas Recombinant Plasma Proteins Market Size by Type (2020-2025)
5.3 Americas Recombinant Plasma Proteins Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Plasma Proteins Market Size by Region (2020-2025)
6.2 APAC Recombinant Plasma Proteins Market Size by Type (2020-2025)
6.3 APAC Recombinant Plasma Proteins Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Recombinant Plasma Proteins Market Size by Country (2020-2025)
7.2 Europe Recombinant Plasma Proteins Market Size by Type (2020-2025)
7.3 Europe Recombinant Plasma Proteins Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant Plasma Proteins by Region (2020-2025)
8.2 Middle East & Africa Recombinant Plasma Proteins Market Size by Type (2020-2025)
8.3 Middle East & Africa Recombinant Plasma Proteins Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RECOMBINANT PLASMA PROTEINS MARKET FORECAST
10.1 Global Recombinant Plasma Proteins Forecast by Region (2026-2031)
10.1.1 Global Recombinant Plasma Proteins Forecast by Region (2026-2031)
10.1.2 Americas Recombinant Plasma Proteins Forecast
10.1.3 APAC Recombinant Plasma Proteins Forecast
10.1.4 Europe Recombinant Plasma Proteins Forecast
10.1.5 Middle East & Africa Recombinant Plasma Proteins Forecast
10.2 Americas Recombinant Plasma Proteins Forecast by Country (2026-2031)
10.2.1 United States Market Recombinant Plasma Proteins Forecast
10.2.2 Canada Market Recombinant Plasma Proteins Forecast
10.2.3 Mexico Market Recombinant Plasma Proteins Forecast
10.2.4 Brazil Market Recombinant Plasma Proteins Forecast
10.3 APAC Recombinant Plasma Proteins Forecast by Region (2026-2031)
10.3.1 China Recombinant Plasma Proteins Market Forecast
10.3.2 Japan Market Recombinant Plasma Proteins Forecast
10.3.3 Korea Market Recombinant Plasma Proteins Forecast
10.3.4 Southeast Asia Market Recombinant Plasma Proteins Forecast
10.3.5 India Market Recombinant Plasma Proteins Forecast
10.3.6 Australia Market Recombinant Plasma Proteins Forecast
10.4 Europe Recombinant Plasma Proteins Forecast by Country (2026-2031)
10.4.1 Germany Market Recombinant Plasma Proteins Forecast
10.4.2 France Market Recombinant Plasma Proteins Forecast
10.4.3 UK Market Recombinant Plasma Proteins Forecast
10.4.4 Italy Market Recombinant Plasma Proteins Forecast
10.4.5 Russia Market Recombinant Plasma Proteins Forecast
10.5 Middle East & Africa Recombinant Plasma Proteins Forecast by Region (2026-2031)
10.5.1 Egypt Market Recombinant Plasma Proteins Forecast
10.5.2 South Africa Market Recombinant Plasma Proteins Forecast
10.5.3 Israel Market Recombinant Plasma Proteins Forecast
10.5.4 Turkey Market Recombinant Plasma Proteins Forecast
10.6 Global Recombinant Plasma Proteins Forecast by Type (2026-2031)
10.7 Global Recombinant Plasma Proteins Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Recombinant Plasma Proteins Forecast
11 KEY PLAYERS ANALYSIS
11.1 CSL Limited
11.1.1 CSL Limited Company Information
11.1.2 CSL Limited Recombinant Plasma Proteins Product Offered
11.1.3 CSL Limited Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 CSL Limited Main Business Overview
11.1.5 CSL Limited Latest Developments
11.2 Shire (Takeda Pharmaceutical Company Limited)
11.2.1 Shire (Takeda Pharmaceutical Company Limited) Company Information
11.2.2 Shire (Takeda Pharmaceutical Company Limited) Recombinant Plasma Proteins Product Offered
11.2.3 Shire (Takeda Pharmaceutical Company Limited) Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Shire (Takeda Pharmaceutical Company Limited) Main Business Overview
11.2.5 Shire (Takeda Pharmaceutical Company Limited) Latest Developments
11.3 Octapharma
11.3.1 Octapharma Company Information
11.3.2 Octapharma Recombinant Plasma Proteins Product Offered
11.3.3 Octapharma Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Octapharma Main Business Overview
11.3.5 Octapharma Latest Developments
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Information
11.4.2 Novo Nordisk Recombinant Plasma Proteins Product Offered
11.4.3 Novo Nordisk Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Novo Nordisk Main Business Overview
11.4.5 Novo Nordisk Latest Developments
11.5 Bayer
11.5.1 Bayer Company Information
11.5.2 Bayer Recombinant Plasma Proteins Product Offered
11.5.3 Bayer Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Bayer Main Business Overview
11.5.5 Bayer Latest Developments
11.6 Bioverativ Therapeutics, Inc. (Sanofi)
11.6.1 Bioverativ Therapeutics, Inc. (Sanofi) Company Information
11.6.2 Bioverativ Therapeutics, Inc. (Sanofi) Recombinant Plasma Proteins Product Offered
11.6.3 Bioverativ Therapeutics, Inc. (Sanofi) Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Bioverativ Therapeutics, Inc. (Sanofi) Main Business Overview
11.6.5 Bioverativ Therapeutics, Inc. (Sanofi) Latest Developments
11.7 Aptevo Therapeutics
11.7.1 Aptevo Therapeutics Company Information
11.7.2 Aptevo Therapeutics Recombinant Plasma Proteins Product Offered
11.7.3 Aptevo Therapeutics Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Aptevo Therapeutics Main Business Overview
11.7.5 Aptevo Therapeutics Latest Developments
11.8 Pharming Group
11.8.1 Pharming Group Company Information
11.8.2 Pharming Group Recombinant Plasma Proteins Product Offered
11.8.3 Pharming Group Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Pharming Group Main Business Overview
11.8.5 Pharming Group Latest Developments
11.9 Pfizer
11.9.1 Pfizer Company Information
11.9.2 Pfizer Recombinant Plasma Proteins Product Offered
11.9.3 Pfizer Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Pfizer Main Business Overview
11.9.5 Pfizer Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant Plasma Proteins Market Size (2020-2031)
2.1.2 Recombinant Plasma Proteins Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Recombinant Plasma Proteins by Country/Region (2020, 2024 & 2031)
2.2 Recombinant Plasma Proteins Segment by Type
2.2.1 Chinese Hamster Ovary (CHO) Cell Line
2.2.2 Baby Hamster Kidney (BHK) Cell Line
2.2.3 Human Embryonic Kidney (HEK) Cell Line
2.2.4 Others
2.3 Recombinant Plasma Proteins Market Size by Type
2.3.1 Recombinant Plasma Proteins Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Recombinant Plasma Proteins Market Size Market Share by Type (2020-2025)
2.4 Recombinant Plasma Proteins Segment by Application
2.4.1 Hemophilia A
2.4.2 Hemophilia B
2.4.3 Von Willebrand Disease
2.4.4 Others
2.5 Recombinant Plasma Proteins Market Size by Application
2.5.1 Recombinant Plasma Proteins Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Recombinant Plasma Proteins Market Size Market Share by Application (2020-2025)
3 RECOMBINANT PLASMA PROTEINS MARKET SIZE BY PLAYER
3.1 Recombinant Plasma Proteins Market Size Market Share by Player
3.1.1 Global Recombinant Plasma Proteins Revenue by Player (2020-2025)
3.1.2 Global Recombinant Plasma Proteins Revenue Market Share by Player (2020-2025)
3.2 Global Recombinant Plasma Proteins Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RECOMBINANT PLASMA PROTEINS BY REGION
4.1 Recombinant Plasma Proteins Market Size by Region (2020-2025)
4.2 Global Recombinant Plasma Proteins Annual Revenue by Country/Region (2020-2025)
4.3 Americas Recombinant Plasma Proteins Market Size Growth (2020-2025)
4.4 APAC Recombinant Plasma Proteins Market Size Growth (2020-2025)
4.5 Europe Recombinant Plasma Proteins Market Size Growth (2020-2025)
4.6 Middle East & Africa Recombinant Plasma Proteins Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Recombinant Plasma Proteins Market Size by Country (2020-2025)
5.2 Americas Recombinant Plasma Proteins Market Size by Type (2020-2025)
5.3 Americas Recombinant Plasma Proteins Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Plasma Proteins Market Size by Region (2020-2025)
6.2 APAC Recombinant Plasma Proteins Market Size by Type (2020-2025)
6.3 APAC Recombinant Plasma Proteins Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Recombinant Plasma Proteins Market Size by Country (2020-2025)
7.2 Europe Recombinant Plasma Proteins Market Size by Type (2020-2025)
7.3 Europe Recombinant Plasma Proteins Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant Plasma Proteins by Region (2020-2025)
8.2 Middle East & Africa Recombinant Plasma Proteins Market Size by Type (2020-2025)
8.3 Middle East & Africa Recombinant Plasma Proteins Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RECOMBINANT PLASMA PROTEINS MARKET FORECAST
10.1 Global Recombinant Plasma Proteins Forecast by Region (2026-2031)
10.1.1 Global Recombinant Plasma Proteins Forecast by Region (2026-2031)
10.1.2 Americas Recombinant Plasma Proteins Forecast
10.1.3 APAC Recombinant Plasma Proteins Forecast
10.1.4 Europe Recombinant Plasma Proteins Forecast
10.1.5 Middle East & Africa Recombinant Plasma Proteins Forecast
10.2 Americas Recombinant Plasma Proteins Forecast by Country (2026-2031)
10.2.1 United States Market Recombinant Plasma Proteins Forecast
10.2.2 Canada Market Recombinant Plasma Proteins Forecast
10.2.3 Mexico Market Recombinant Plasma Proteins Forecast
10.2.4 Brazil Market Recombinant Plasma Proteins Forecast
10.3 APAC Recombinant Plasma Proteins Forecast by Region (2026-2031)
10.3.1 China Recombinant Plasma Proteins Market Forecast
10.3.2 Japan Market Recombinant Plasma Proteins Forecast
10.3.3 Korea Market Recombinant Plasma Proteins Forecast
10.3.4 Southeast Asia Market Recombinant Plasma Proteins Forecast
10.3.5 India Market Recombinant Plasma Proteins Forecast
10.3.6 Australia Market Recombinant Plasma Proteins Forecast
10.4 Europe Recombinant Plasma Proteins Forecast by Country (2026-2031)
10.4.1 Germany Market Recombinant Plasma Proteins Forecast
10.4.2 France Market Recombinant Plasma Proteins Forecast
10.4.3 UK Market Recombinant Plasma Proteins Forecast
10.4.4 Italy Market Recombinant Plasma Proteins Forecast
10.4.5 Russia Market Recombinant Plasma Proteins Forecast
10.5 Middle East & Africa Recombinant Plasma Proteins Forecast by Region (2026-2031)
10.5.1 Egypt Market Recombinant Plasma Proteins Forecast
10.5.2 South Africa Market Recombinant Plasma Proteins Forecast
10.5.3 Israel Market Recombinant Plasma Proteins Forecast
10.5.4 Turkey Market Recombinant Plasma Proteins Forecast
10.6 Global Recombinant Plasma Proteins Forecast by Type (2026-2031)
10.7 Global Recombinant Plasma Proteins Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Recombinant Plasma Proteins Forecast
11 KEY PLAYERS ANALYSIS
11.1 CSL Limited
11.1.1 CSL Limited Company Information
11.1.2 CSL Limited Recombinant Plasma Proteins Product Offered
11.1.3 CSL Limited Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 CSL Limited Main Business Overview
11.1.5 CSL Limited Latest Developments
11.2 Shire (Takeda Pharmaceutical Company Limited)
11.2.1 Shire (Takeda Pharmaceutical Company Limited) Company Information
11.2.2 Shire (Takeda Pharmaceutical Company Limited) Recombinant Plasma Proteins Product Offered
11.2.3 Shire (Takeda Pharmaceutical Company Limited) Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Shire (Takeda Pharmaceutical Company Limited) Main Business Overview
11.2.5 Shire (Takeda Pharmaceutical Company Limited) Latest Developments
11.3 Octapharma
11.3.1 Octapharma Company Information
11.3.2 Octapharma Recombinant Plasma Proteins Product Offered
11.3.3 Octapharma Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Octapharma Main Business Overview
11.3.5 Octapharma Latest Developments
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Information
11.4.2 Novo Nordisk Recombinant Plasma Proteins Product Offered
11.4.3 Novo Nordisk Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Novo Nordisk Main Business Overview
11.4.5 Novo Nordisk Latest Developments
11.5 Bayer
11.5.1 Bayer Company Information
11.5.2 Bayer Recombinant Plasma Proteins Product Offered
11.5.3 Bayer Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Bayer Main Business Overview
11.5.5 Bayer Latest Developments
11.6 Bioverativ Therapeutics, Inc. (Sanofi)
11.6.1 Bioverativ Therapeutics, Inc. (Sanofi) Company Information
11.6.2 Bioverativ Therapeutics, Inc. (Sanofi) Recombinant Plasma Proteins Product Offered
11.6.3 Bioverativ Therapeutics, Inc. (Sanofi) Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Bioverativ Therapeutics, Inc. (Sanofi) Main Business Overview
11.6.5 Bioverativ Therapeutics, Inc. (Sanofi) Latest Developments
11.7 Aptevo Therapeutics
11.7.1 Aptevo Therapeutics Company Information
11.7.2 Aptevo Therapeutics Recombinant Plasma Proteins Product Offered
11.7.3 Aptevo Therapeutics Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Aptevo Therapeutics Main Business Overview
11.7.5 Aptevo Therapeutics Latest Developments
11.8 Pharming Group
11.8.1 Pharming Group Company Information
11.8.2 Pharming Group Recombinant Plasma Proteins Product Offered
11.8.3 Pharming Group Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Pharming Group Main Business Overview
11.8.5 Pharming Group Latest Developments
11.9 Pfizer
11.9.1 Pfizer Company Information
11.9.2 Pfizer Recombinant Plasma Proteins Product Offered
11.9.3 Pfizer Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Pfizer Main Business Overview
11.9.5 Pfizer Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Recombinant Plasma Proteins Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Recombinant Plasma Proteins Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Chinese Hamster Ovary (CHO) Cell Line
Table 4. Major Players of Baby Hamster Kidney (BHK) Cell Line
Table 5. Major Players of Human Embryonic Kidney (HEK) Cell Line
Table 6. Major Players of Others
Table 7. Recombinant Plasma Proteins Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Recombinant Plasma Proteins Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Recombinant Plasma Proteins Market Size Market Share by Type (2020-2025)
Table 10. Recombinant Plasma Proteins Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Recombinant Plasma Proteins Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Recombinant Plasma Proteins Market Size Market Share by Application (2020-2025)
Table 13. Global Recombinant Plasma Proteins Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Recombinant Plasma Proteins Revenue Market Share by Player (2020-2025)
Table 15. Recombinant Plasma Proteins Key Players Head office and Products Offered
Table 16. Recombinant Plasma Proteins Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Recombinant Plasma Proteins Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Recombinant Plasma Proteins Market Size Market Share by Region (2020-2025)
Table 21. Global Recombinant Plasma Proteins Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Recombinant Plasma Proteins Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Recombinant Plasma Proteins Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Recombinant Plasma Proteins Market Size Market Share by Country (2020-2025)
Table 25. Americas Recombinant Plasma Proteins Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Recombinant Plasma Proteins Market Size Market Share by Type (2020-2025)
Table 27. Americas Recombinant Plasma Proteins Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Recombinant Plasma Proteins Market Size Market Share by Application (2020-2025)
Table 29. APAC Recombinant Plasma Proteins Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Recombinant Plasma Proteins Market Size Market Share by Region (2020-2025)
Table 31. APAC Recombinant Plasma Proteins Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Recombinant Plasma Proteins Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Recombinant Plasma Proteins Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Recombinant Plasma Proteins Market Size Market Share by Country (2020-2025)
Table 35. Europe Recombinant Plasma Proteins Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Recombinant Plasma Proteins Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Recombinant Plasma Proteins Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Recombinant Plasma Proteins Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Recombinant Plasma Proteins Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Recombinant Plasma Proteins
Table 41. Key Market Challenges & Risks of Recombinant Plasma Proteins
Table 42. Key Industry Trends of Recombinant Plasma Proteins
Table 43. Global Recombinant Plasma Proteins Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Recombinant Plasma Proteins Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Recombinant Plasma Proteins Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Recombinant Plasma Proteins Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. CSL Limited Details, Company Type, Recombinant Plasma Proteins Area Served and Its Competitors
Table 48. CSL Limited Recombinant Plasma Proteins Product Offered
Table 49. CSL Limited Recombinant Plasma Proteins Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. CSL Limited Main Business
Table 51. CSL Limited Latest Developments
Table 52. Shire (Takeda Pharmaceutical Company Limited) Details, Company Type, Recombinant Plasma Proteins Area Served and Its Competitors
Table 53. Shire (Takeda Pharmaceutical Company Limited) Recombinant Plasma Proteins Product Offered
Table 54. Shire (Takeda Pharmaceutical Company Limited) Recombinant Plasma Proteins Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Shire (Takeda Pharmaceutical Company Limited) Main Business
Table 56. Shire (Takeda Pharmaceutical Company Limited) Latest Developments
Table 57. Octapharma Details, Company Type, Recombinant Plasma Proteins Area Served and Its Competitors
Table 58. Octapharma Recombinant Plasma Proteins Product Offered
Table 59. Octapharma Recombinant Plasma Proteins Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Octapharma Main Business
Table 61. Octapharma Latest Developments
Table 62. Novo Nordisk Details, Company Type, Recombinant Plasma Proteins Area Served and Its Competitors
Table 63. Novo Nordisk Recombinant Plasma Proteins Product Offered
Table 64. Novo Nordisk Recombinant Plasma Proteins Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Novo Nordisk Main Business
Table 66. Novo Nordisk Latest Developments
Table 67. Bayer Details, Company Type, Recombinant Plasma Proteins Area Served and Its Competitors
Table 68. Bayer Recombinant Plasma Proteins Product Offered
Table 69. Bayer Recombinant Plasma Proteins Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Bayer Main Business
Table 71. Bayer Latest Developments
Table 72. Bioverativ Therapeutics, Inc. (Sanofi) Details, Company Type, Recombinant Plasma Proteins Area Served and Its Competitors
Table 73. Bioverativ Therapeutics, Inc. (Sanofi) Recombinant Plasma Proteins Product Offered
Table 74. Bioverativ Therapeutics, Inc. (Sanofi) Recombinant Plasma Proteins Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Bioverativ Therapeutics, Inc. (Sanofi) Main Business
Table 76. Bioverativ Therapeutics, Inc. (Sanofi) Latest Developments
Table 77. Aptevo Therapeutics Details, Company Type, Recombinant Plasma Proteins Area Served and Its Competitors
Table 78. Aptevo Therapeutics Recombinant Plasma Proteins Product Offered
Table 79. Aptevo Therapeutics Recombinant Plasma Proteins Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Aptevo Therapeutics Main Business
Table 81. Aptevo Therapeutics Latest Developments
Table 82. Pharming Group Details, Company Type, Recombinant Plasma Proteins Area Served and Its Competitors
Table 83. Pharming Group Recombinant Plasma Proteins Product Offered
Table 84. Pharming Group Recombinant Plasma Proteins Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. Pharming Group Main Business
Table 86. Pharming Group Latest Developments
Table 87. Pfizer Details, Company Type, Recombinant Plasma Proteins Area Served and Its Competitors
Table 88. Pfizer Recombinant Plasma Proteins Product Offered
Table 89. Pfizer Recombinant Plasma Proteins Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. Pfizer Main Business
Table 91. Pfizer Latest Developments
Table 1. Recombinant Plasma Proteins Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Recombinant Plasma Proteins Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Chinese Hamster Ovary (CHO) Cell Line
Table 4. Major Players of Baby Hamster Kidney (BHK) Cell Line
Table 5. Major Players of Human Embryonic Kidney (HEK) Cell Line
Table 6. Major Players of Others
Table 7. Recombinant Plasma Proteins Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Recombinant Plasma Proteins Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Recombinant Plasma Proteins Market Size Market Share by Type (2020-2025)
Table 10. Recombinant Plasma Proteins Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Recombinant Plasma Proteins Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Recombinant Plasma Proteins Market Size Market Share by Application (2020-2025)
Table 13. Global Recombinant Plasma Proteins Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Recombinant Plasma Proteins Revenue Market Share by Player (2020-2025)
Table 15. Recombinant Plasma Proteins Key Players Head office and Products Offered
Table 16. Recombinant Plasma Proteins Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Recombinant Plasma Proteins Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Recombinant Plasma Proteins Market Size Market Share by Region (2020-2025)
Table 21. Global Recombinant Plasma Proteins Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Recombinant Plasma Proteins Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Recombinant Plasma Proteins Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Recombinant Plasma Proteins Market Size Market Share by Country (2020-2025)
Table 25. Americas Recombinant Plasma Proteins Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Recombinant Plasma Proteins Market Size Market Share by Type (2020-2025)
Table 27. Americas Recombinant Plasma Proteins Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Recombinant Plasma Proteins Market Size Market Share by Application (2020-2025)
Table 29. APAC Recombinant Plasma Proteins Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Recombinant Plasma Proteins Market Size Market Share by Region (2020-2025)
Table 31. APAC Recombinant Plasma Proteins Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Recombinant Plasma Proteins Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Recombinant Plasma Proteins Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Recombinant Plasma Proteins Market Size Market Share by Country (2020-2025)
Table 35. Europe Recombinant Plasma Proteins Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Recombinant Plasma Proteins Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Recombinant Plasma Proteins Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Recombinant Plasma Proteins Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Recombinant Plasma Proteins Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Recombinant Plasma Proteins
Table 41. Key Market Challenges & Risks of Recombinant Plasma Proteins
Table 42. Key Industry Trends of Recombinant Plasma Proteins
Table 43. Global Recombinant Plasma Proteins Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Recombinant Plasma Proteins Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Recombinant Plasma Proteins Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Recombinant Plasma Proteins Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. CSL Limited Details, Company Type, Recombinant Plasma Proteins Area Served and Its Competitors
Table 48. CSL Limited Recombinant Plasma Proteins Product Offered
Table 49. CSL Limited Recombinant Plasma Proteins Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. CSL Limited Main Business
Table 51. CSL Limited Latest Developments
Table 52. Shire (Takeda Pharmaceutical Company Limited) Details, Company Type, Recombinant Plasma Proteins Area Served and Its Competitors
Table 53. Shire (Takeda Pharmaceutical Company Limited) Recombinant Plasma Proteins Product Offered
Table 54. Shire (Takeda Pharmaceutical Company Limited) Recombinant Plasma Proteins Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Shire (Takeda Pharmaceutical Company Limited) Main Business
Table 56. Shire (Takeda Pharmaceutical Company Limited) Latest Developments
Table 57. Octapharma Details, Company Type, Recombinant Plasma Proteins Area Served and Its Competitors
Table 58. Octapharma Recombinant Plasma Proteins Product Offered
Table 59. Octapharma Recombinant Plasma Proteins Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Octapharma Main Business
Table 61. Octapharma Latest Developments
Table 62. Novo Nordisk Details, Company Type, Recombinant Plasma Proteins Area Served and Its Competitors
Table 63. Novo Nordisk Recombinant Plasma Proteins Product Offered
Table 64. Novo Nordisk Recombinant Plasma Proteins Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Novo Nordisk Main Business
Table 66. Novo Nordisk Latest Developments
Table 67. Bayer Details, Company Type, Recombinant Plasma Proteins Area Served and Its Competitors
Table 68. Bayer Recombinant Plasma Proteins Product Offered
Table 69. Bayer Recombinant Plasma Proteins Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Bayer Main Business
Table 71. Bayer Latest Developments
Table 72. Bioverativ Therapeutics, Inc. (Sanofi) Details, Company Type, Recombinant Plasma Proteins Area Served and Its Competitors
Table 73. Bioverativ Therapeutics, Inc. (Sanofi) Recombinant Plasma Proteins Product Offered
Table 74. Bioverativ Therapeutics, Inc. (Sanofi) Recombinant Plasma Proteins Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Bioverativ Therapeutics, Inc. (Sanofi) Main Business
Table 76. Bioverativ Therapeutics, Inc. (Sanofi) Latest Developments
Table 77. Aptevo Therapeutics Details, Company Type, Recombinant Plasma Proteins Area Served and Its Competitors
Table 78. Aptevo Therapeutics Recombinant Plasma Proteins Product Offered
Table 79. Aptevo Therapeutics Recombinant Plasma Proteins Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Aptevo Therapeutics Main Business
Table 81. Aptevo Therapeutics Latest Developments
Table 82. Pharming Group Details, Company Type, Recombinant Plasma Proteins Area Served and Its Competitors
Table 83. Pharming Group Recombinant Plasma Proteins Product Offered
Table 84. Pharming Group Recombinant Plasma Proteins Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. Pharming Group Main Business
Table 86. Pharming Group Latest Developments
Table 87. Pfizer Details, Company Type, Recombinant Plasma Proteins Area Served and Its Competitors
Table 88. Pfizer Recombinant Plasma Proteins Product Offered
Table 89. Pfizer Recombinant Plasma Proteins Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. Pfizer Main Business
Table 91. Pfizer Latest Developments
LIST OF FIGURES
Figure 1. Recombinant Plasma Proteins Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Recombinant Plasma Proteins Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Recombinant Plasma Proteins Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Recombinant Plasma Proteins Sales Market Share by Country/Region (2024)
Figure 8. Recombinant Plasma Proteins Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Recombinant Plasma Proteins Market Size Market Share by Type in 2024
Figure 10. Recombinant Plasma Proteins in Hemophilia A
Figure 11. Global Recombinant Plasma Proteins Market: Hemophilia A (2020-2025) & ($ millions)
Figure 12. Recombinant Plasma Proteins in Hemophilia B
Figure 13. Global Recombinant Plasma Proteins Market: Hemophilia B (2020-2025) & ($ millions)
Figure 14. Recombinant Plasma Proteins in Von Willebrand Disease
Figure 15. Global Recombinant Plasma Proteins Market: Von Willebrand Disease (2020-2025) & ($ millions)
Figure 16. Recombinant Plasma Proteins in Others
Figure 17. Global Recombinant Plasma Proteins Market: Others (2020-2025) & ($ millions)
Figure 18. Global Recombinant Plasma Proteins Market Size Market Share by Application in 2024
Figure 19. Global Recombinant Plasma Proteins Revenue Market Share by Player in 2024
Figure 20. Global Recombinant Plasma Proteins Market Size Market Share by Region (2020-2025)
Figure 21. Americas Recombinant Plasma Proteins Market Size 2020-2025 ($ millions)
Figure 22. APAC Recombinant Plasma Proteins Market Size 2020-2025 ($ millions)
Figure 23. Europe Recombinant Plasma Proteins Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Recombinant Plasma Proteins Market Size 2020-2025 ($ millions)
Figure 25. Americas Recombinant Plasma Proteins Value Market Share by Country in 2024
Figure 26. United States Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Recombinant Plasma Proteins Market Size Market Share by Region in 2024
Figure 31. APAC Recombinant Plasma Proteins Market Size Market Share by Type (2020-2025)
Figure 32. APAC Recombinant Plasma Proteins Market Size Market Share by Application (2020-2025)
Figure 33. China Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 37. India Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Recombinant Plasma Proteins Market Size Market Share by Country in 2024
Figure 40. Europe Recombinant Plasma Proteins Market Size Market Share by Type (2020-2025)
Figure 41. Europe Recombinant Plasma Proteins Market Size Market Share by Application (2020-2025)
Figure 42. Germany Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 43. France Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Recombinant Plasma Proteins Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Recombinant Plasma Proteins Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Recombinant Plasma Proteins Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 56. APAC Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 57. Europe Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 59. United States Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 60. Canada Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 61. Mexico Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 62. Brazil Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 63. China Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 64. Japan Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 65. Korea Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 67. India Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 68. Australia Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 69. Germany Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 70. France Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 71. UK Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 72. Italy Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 73. Russia Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 74. Egypt Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 75. South Africa Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 76. Israel Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 77. Turkey Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 78. Global Recombinant Plasma Proteins Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Recombinant Plasma Proteins Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 1. Recombinant Plasma Proteins Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Recombinant Plasma Proteins Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Recombinant Plasma Proteins Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Recombinant Plasma Proteins Sales Market Share by Country/Region (2024)
Figure 8. Recombinant Plasma Proteins Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Recombinant Plasma Proteins Market Size Market Share by Type in 2024
Figure 10. Recombinant Plasma Proteins in Hemophilia A
Figure 11. Global Recombinant Plasma Proteins Market: Hemophilia A (2020-2025) & ($ millions)
Figure 12. Recombinant Plasma Proteins in Hemophilia B
Figure 13. Global Recombinant Plasma Proteins Market: Hemophilia B (2020-2025) & ($ millions)
Figure 14. Recombinant Plasma Proteins in Von Willebrand Disease
Figure 15. Global Recombinant Plasma Proteins Market: Von Willebrand Disease (2020-2025) & ($ millions)
Figure 16. Recombinant Plasma Proteins in Others
Figure 17. Global Recombinant Plasma Proteins Market: Others (2020-2025) & ($ millions)
Figure 18. Global Recombinant Plasma Proteins Market Size Market Share by Application in 2024
Figure 19. Global Recombinant Plasma Proteins Revenue Market Share by Player in 2024
Figure 20. Global Recombinant Plasma Proteins Market Size Market Share by Region (2020-2025)
Figure 21. Americas Recombinant Plasma Proteins Market Size 2020-2025 ($ millions)
Figure 22. APAC Recombinant Plasma Proteins Market Size 2020-2025 ($ millions)
Figure 23. Europe Recombinant Plasma Proteins Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Recombinant Plasma Proteins Market Size 2020-2025 ($ millions)
Figure 25. Americas Recombinant Plasma Proteins Value Market Share by Country in 2024
Figure 26. United States Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Recombinant Plasma Proteins Market Size Market Share by Region in 2024
Figure 31. APAC Recombinant Plasma Proteins Market Size Market Share by Type (2020-2025)
Figure 32. APAC Recombinant Plasma Proteins Market Size Market Share by Application (2020-2025)
Figure 33. China Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 37. India Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Recombinant Plasma Proteins Market Size Market Share by Country in 2024
Figure 40. Europe Recombinant Plasma Proteins Market Size Market Share by Type (2020-2025)
Figure 41. Europe Recombinant Plasma Proteins Market Size Market Share by Application (2020-2025)
Figure 42. Germany Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 43. France Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Recombinant Plasma Proteins Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Recombinant Plasma Proteins Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Recombinant Plasma Proteins Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Recombinant Plasma Proteins Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 56. APAC Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 57. Europe Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 59. United States Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 60. Canada Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 61. Mexico Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 62. Brazil Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 63. China Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 64. Japan Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 65. Korea Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 67. India Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 68. Australia Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 69. Germany Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 70. France Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 71. UK Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 72. Italy Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 73. Russia Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 74. Egypt Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 75. South Africa Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 76. Israel Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 77. Turkey Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
Figure 78. Global Recombinant Plasma Proteins Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Recombinant Plasma Proteins Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Recombinant Plasma Proteins Market Size 2026-2031 ($ millions)
